NCT03491670 (DESFER) is a clinical trial in Arrest Cardio Respiratory, sponsored by University Hospital, Brest.

Who is sponsoring NCT03491670?

NCT03491670 is sponsored by University Hospital, Brest.

What condition does NCT03491670 study?

NCT03491670 studies Arrest Cardio Respiratory.

Is NCT03491670 still recruiting?

NCT03491670 is currently completed. Last updated 8 October 2020.

Last reviewed 2020-10-08 · How we verify

NCT03491670: DESFER

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Free Iron and Out of Hospital Cardiac Arrest

Completed Last updated 8 October 2020

What this trial tests

trial in Arrest Cardio Respiratory in 25 participants. Completed in 16 July 2019.

Timeline

5 June 2018

Primary endpoint
5 June 2019

16 July 2019

Quick facts

Lead sponsor	University Hospital, Brest
Status	Completed
Study type	OBSERVATIONAL
Enrollment	25
Start date	5 June 2018
Primary completion	5 June 2019
Estimated completion	16 July 2019
Sites	1 location across France

Conditions studied

Arrest Cardio Respiratory — all drugs for Arrest Cardio Respiratory →

Sponsor

University Hospital, Brest

Who can join

18 and older, any sex, with Arrest Cardio Respiratory. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Out of hospital cardiac arrest is associated with a poor prognosis. The aim of this study is to provide a better understanding of perturbations of iron metabolism after cardiac arrest and to analyze the impact on clinical centered outcome.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

40th International Symposium on Intensive Care & Emergency Medicine : Brussels, Belgium. 24-27 March 2020.
· 2020 · cited 6× · PMID 32209112 · DOI 10.1186/s13054-020-2772-3

Verify or expand the search:

Other University Hospital, Brest trials

Trials by the same sponsor.

NCT07526688 — Aerobic Physical Activity and Orofacial Myofascial Pain · NA · not yet recruiting
NCT07487155 — Unified Junction of Care, Integrated Treatments and Team Coordination for ADHD in Prison Settings With Substance Use Dis · NA · not yet recruiting
NCT07417605 — Diagnostic Performance Of 4D Dynamic LAFOV FDG-PET Acquisition for Differentiation of Residual Disease and Post-radiatio · not yet recruiting
NCT07302074 — Understanding of Rare Inflammatory Arthritis in Comparison to Classical Inflammatory Arthritis : Tissular Observations a · NA · recruiting
NCT06441773 — Impact of Respiratory Rehabilitation on Quality of Life in Patients With Metastatic Non-small Cell Lung Cancer Treated W · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03491670 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Brest
Last refreshed: 8 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03491670.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing